Alerts will be sent to your verified email
Verify EmailHEMORGANIC
Hemo Organic
|
Raymed Labs
|
Zyden Gentec
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-343.55 % | 4.33 % | -24.76 % |
5yr average Equity Multiplier
|
4.83 | -0.1 | 2.0 |
5yr Average Asset Turnover Ratio
|
0.56 | 0.0 | 0.21 |
5yr Avg Net Profit Margin
|
-766.15 % | 0.0 | -137.59 % |
Price to Book
|
0.0 | 0.0 | n/a |
P/E
|
0.0 | 0.0 | n/a |
5yr Avg Cash Conversion Cycle
|
-1382.2 Days | 0.0 | 785.76 Days |
Inventory Days
|
364.55 Days | 0.0 | 134.34 Days |
Days Receivable
|
1156.1 Days | 0.0 | 803.05 Days |
Days Payable
|
2873.52 Days | 0.0 | 421.99 Days |
5yr Average Interest Coverage Ratio
|
-254.04 | -1369.03 | -2.08 |
5yr Avg ROCE
|
52.28 % | -157.79 % | -6.92 % |
5yr Avg Operating Profit Margin
|
-746.74 % | 0.0 | -95.87 % |
5 yr average Debt to Equity
|
1.23 | -0.41 | 0.68 |
5yr CAGR Net Profit
|
67.03 % | 10.76 % | -1.66 % |
5yr Average Return on Assets
|
-38.14 % | -51.92 % | -15.88 % |
Shareholdings
|
|||
Promoter Holding
|
16.85 % | 32.27 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 3.91 % | -17.28 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Hemo Organic
|
Raymed Labs
|
Zyden Gentec
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|